MedTrace Logo

IVL for Stent Underexpantsion

NCT05112250 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 62

Last updated 2021-11-08

No results posted yet for this study

Summary

The IVL-Dragon Registry was a multicenter study that enrolled consecutive patients with stent underexpansion treated with IVL in high-volume PCI centers. The primary efficacy endpoint was clinical success, defined as a reduction of stent underexpansion to \<30% with no evidence of in-hospital device-oriented composite end point (DOCE) (defined as a composite of cardiac death, target lesion revascularization, and target vessel myocardial infarction).

Conditions

  • In Stent Restenosis
  • Coronary Artery Calcification
  • Intravascular Lithotripsy

Interventions

DEVICE

Percutaneous Coronary Intervention

Intravascular lithotripsy (IVL)

Sponsors & Collaborators

  • Wojciech Wojakowski

    collaborator UNKNOWN

  • Medical University of Silesia

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-01
Primary Completion
2021-04-01
Completion
2021-04-01

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05112250 on ClinicalTrials.gov